Back
TScan Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
38
TCRX
TScan Therapeutics, Inc.
Last Price:
$1.07
Seasonality Move:
1.49%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is relatively stagnant and TCRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
TScan Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.95 | Buy |
| 20-day SMA: | 1 | Buy |
| 50-day SMA: | 1.33 | Sell |
| 200-day SMA: | 1.56 | Sell |
| 8-day EMA: | 0.98 | Buy |
| 20-day EMA: | 1.02 | Buy |
| 50-day EMA: | 1.23 | Sell |
| 200-day EMA: | 1.88 | Sell |
TScan Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.07 | Sell |
| Relative Strength Index (14 RSI): | 49.52 | Sell |
| Chaikin Money Flow: | 484107 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.94 - 1.06) | Buy |
| Bollinger Bands (100): | (1.12 - 2.06) | Sell |
TScan Therapeutics, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for TScan Therapeutics, Inc. Stock
Is TScan Therapeutics, Inc. Stock a Buy?
-
TScan Therapeutics, Inc. share price is 1.06 while TCRX 8-day simple moving average is 0.95, which is a Buy signal.
-
The stock price of TCRX is 1.06 while TScan Therapeutics, Inc. 20-day SMA is 1.00, which makes it a Buy.
-
TScan Therapeutics, Inc. 50-day simple moving average is 1.33 while TCRX share price is 1.06, making it a Sell technically.
-
TCRX stock price is 1.06 and TScan Therapeutics, Inc. 200-day simple moving average is 1.56, creating a Sell signal.
TCRX Technical Analysis vs Fundamental Analysis
Sell
38
TScan Therapeutics, Inc. (TCRX)
is a Sell
Is TScan Therapeutics, Inc. a Buy or a Sell?
-
TScan Therapeutics, Inc. stock is rated a SellThe current TScan Therapeutics, Inc. [TCRX] share price is $1.06. The Score for TCRX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
TScan Therapeutics, Inc. Stock Info
Market Cap:
60.2M
Price in USD:
1.06
Share Volume:
626.7K
TScan Therapeutics, Inc. 52-Week Range
52-Week High:
3.21
52-Week Low:
0.88
Sell
38
TScan Therapeutics, Inc. (TCRX)
is a Sell
TScan Therapeutics, Inc. Share Price Forecast
-
What is the TScan Therapeutics, Inc. stock price today?The TScan Therapeutics, Inc. stock price is 1.06 USD today.
-
Will TCRX stock go up or go down?TScan Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is TScan Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, TScan Therapeutics, Inc. is overvalued.
Is TScan Therapeutics, Inc. Stock a Buy?
-
TScan Therapeutics, Inc. share price is 1.06 while TCRX 8-day exponential moving average is 0.98, which is a Buy signal.
-
The stock price of TCRX is 1.06 while TScan Therapeutics, Inc. 20-day EMA is 1.02, which makes it a Buy.
-
TScan Therapeutics, Inc. 50-day exponential moving average is 1.23 while TCRX share price is 1.06, making it a Sell technically.
-
TCRX stock price is 1.06 and TScan Therapeutics, Inc. 200-day simple moving average is 1.88, creating a Sell signal.
Fundamental Analysis of TScan Therapeutics, Inc.
Is TScan Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and an increase next year of $0.24 per share.
Technical Analysis of TScan Therapeutics, Inc.
Should I short TScan Therapeutics, Inc. stock?
-
TCRX Moving Average Covergence Divergence (MACD) indicator is -0.07, suggesting TScan Therapeutics, Inc. is a Sell
-
TScan Therapeutics, Inc. Relative Strength Index (RSI) is 49.52, which suggest TScan Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for TScan Therapeutics, Inc. is (0.94 - 1.06), which suggest TScan Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for TScan Therapeutics, Inc. is (1.12 - 2.06), which suggest TScan Therapeutics, Inc. is a Sell
* TScan Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.